These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21666889)

  • 41. In vivo experimental approach to treatment against tabun poisoning.
    Berend S; Katalinić M; Vrdoljak AL; Kovarik Z; Kuca K; Radić B
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):531-6. PubMed ID: 20235800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A comparison of the efficacy of the reactivators of acetylcholinesterase inhibited with tabun].
    Cabal J; Kuca K; Jun D; Bajgar J; Hrabinová M
    Ceska Slov Farm; 2005 Jul; 54(4):192-5. PubMed ID: 16124202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuroprotective effects of currently used antidotes in soman-poisoned rats.
    Kassa J; Koupilová M
    Pharmacol Biochem Behav; 2000 Nov; 67(3):663-8. PubMed ID: 11164099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes of rat plasma total low molecular weight antioxidant level after tabun exposure and consequent treatment by acetylcholinesterase reactivators.
    Pohanka M; Karasova JZ; Musilek K; Kuca K; Jung YS; Kassa J
    J Enzyme Inhib Med Chem; 2011 Feb; 26(1):93-7. PubMed ID: 20569082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agent.
    Jeong HC; Park NJ; Chae CH; Musilek K; Kassa J; Kuca K; Jung YS
    Bioorg Med Chem; 2009 Sep; 17(17):6213-7. PubMed ID: 19665386
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of antidotal effects of adamantyl derivative Tamorf in soman poisoning.
    Lucić Vrdoljak A; Radić B; Garaj-Vrhovac V; Kopjar N; Zlender V
    J Appl Toxicol; 2006; 26(1):56-63. PubMed ID: 16167315
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of diazepam on the effectiveness of antidote therapy in eliminating the acute lethal effects of soman in mice].
    Kassa J
    Cas Lek Cesk; 2001 Aug; 140(16):497-9. PubMed ID: 11678028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antidotal efficacy of quinuclidinium oximes against soman poisoning.
    Lucić A; Radić B; Peraica M; Mesić M; Primozic I; Binenfeld Z
    Arch Toxicol; 1997; 71(7):467-70. PubMed ID: 9209694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo protection studies of bis-quaternary 2-(hydroxyimino)- N-(pyridin-3-yl) acetamide derivatives (HNK oximes) against tabun and soman poisoning in Swiss albino mice.
    Kumar P; Swami D; Nagar DP; Singh KP; Acharya J; Karade HN; Yadav R
    Hum Exp Toxicol; 2017 Dec; 36(12):1270-1285. PubMed ID: 28078916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dose Dependent Prophylactic Efficacy of 6-Chlorotacrine in Soman-Poisoned Mice.
    Kassa J; Korábečný J
    Acta Medica (Hradec Kralove); 2017; 60(4):140-145. PubMed ID: 29716679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oxime reactivation of RBC acetylcholinesterases for biomonitoring.
    Hansen ME; Wilson BW
    Arch Environ Contam Toxicol; 1999 Oct; 37(3):283-9. PubMed ID: 10473783
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reactivation of soman inhibited acetylcholinesterase in vitro and protection against soman in vivo by bispyridinium-2-aldoximes.
    Schoene K; Steinhanses J; Oldiges H
    Biochem Pharmacol; 1983 May; 32(10):1649-51. PubMed ID: 6860352
    [No Abstract]   [Full Text] [Related]  

  • 53. Quaternary salts of 3,3'-bis-pyridinium monooximes: synthesis and biological activity.
    Sikder AK; Ghosh AK; Jaiswal DK
    J Pharm Sci; 1993 Mar; 82(3):258-61. PubMed ID: 8450418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiovascular consequences of organophosphorus poisoning and of antidotes in conscious unrestrained rats.
    Bataillard A; Sannajust F; Yoccoz D; Blanchet G; Sentenac-Roumanou H; Sassard J
    Pharmacol Toxicol; 1990 Jul; 67(1):27-35. PubMed ID: 2395813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intoxications with anticholinesterases: effect of different combinations of antidotes on the dynamics of acetylcholine in mouse brain.
    Nordgren I; Karlén B; Kimland M; Palmér L; Holmstedt B
    Pharmacol Toxicol; 1992 May; 70(5 Pt 1):384-8. PubMed ID: 1608928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Galantamine is a novel post-exposure therapeutic against lethal VX challenge.
    Hilmas CJ; Poole MJ; Finneran K; Clark MG; Williams PT
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):166-73. PubMed ID: 19647007
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pralidoxime in carbaryl poisoning: an animal model.
    Mercurio-Zappala M; Hack JB; Salvador A; Hoffman RS
    Hum Exp Toxicol; 2007 Feb; 26(2):125-9. PubMed ID: 17370870
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo protection against soman toxicity by known inhibitors of acetylcholine synthesis in vitro.
    Sterling GH; Doukas PH; Sheldon RJ; O'Neill JJ
    Biochem Pharmacol; 1988 Feb; 37(3):379-84. PubMed ID: 3337738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The evaluation of prophylactic efficacy of newly developed reversible inhibitors of acetylcholinesterase in soman-poisoned mice - a comparison with commonly used pyridostigmine.
    Kassa J; Korabecny J; Sepsova V; Tumova M
    Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):571-6. PubMed ID: 24842281
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Using MRI for the assessment of paraoxon-induced brain damage and efficacy of antidotal treatment.
    Rosman Y; Eisenkraft A; Krivoy A; Schein O; Makarovski I; Shrot S; Ramaty E; Shilderman EB; Kapon J; Gilat E; Kadar T; Maier S; Daniels D; Shneor R; Salomon S; Tamar G; Last D; Mardor Y
    J Appl Toxicol; 2012 Jun; 32(6):409-16. PubMed ID: 21861267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.